Hormone Research in Paediatrics
Original Paper
Anti-Zinc Transporter Protein 8 Antibody Testing Is Not Informative in Routine Prediabetes Screening in Young Patients with Autoimmune Thyroiditis and Celiac DiseaseLarizza D.a, b · De Amici M.c · Klersy C.d · Albanesi M.a, b · Albertini R.e · Badulli C.e · Torre C.c · Calcaterra V.a, baDepartment of Internal Medicine, University of Pavia, and bDepartment of Maternal and Children's Health, Pediatric Endocrinology Unit, bImmuno-Allergy Laboratory of the Pediatric Clinic, cBiometry and Clinical Epidemiology, Scientific Direction, and dLaboratory of Clinical Chemistry, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: May 03, 2016
Accepted: June 24, 2016
Published online: August 03, 2016
Issue release date: October 2016
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Abstract
Background/Aims: Patients with type 1 diabetes mellitus (T1DM), autoimmune thyroiditis (ATD), and celiac disease (CD) are at increased risk for developing other autoimmune diseases. We evaluated zinc transporter 8 (ZnT8) prevalence in patients with ATD and/or CD in order to define the usefulness of ZnT8 autoantibodies for prediabetes screening. Methods: Eighty-one young patients with ATD and/or CD were included in the study; 32 subjects with clinical onset of T1DM were enrolled as a control group. GAD65, IA-2, and ZnT8 antibodies were measured. An intravenous glucose tolerance test, C-peptide, glycosylated hemoglobin levels, and genomic analysis of HLA-DQA1* and -DQB1* were also considered in patients positive for autoantibodies. Results: The ZnT8 prevalence was higher in T1DM patients than in patients with other autoimmune diseases (p < 0.001); positive ZnT8 detection was found in 2 ATD (p = 0.004) and 3 ATD + CD (p = 0.04) patients. Positive ZnT8 was associated with GAD65 (p = 0.01) but not with IA-2 positivity. No correlation between ZnT8 detection and the number of T1DM-susceptible HLA-DQ heterodimers was found. Pathological C-peptide levels and insulin response were found in subjects with islet autoimmunity and genetic susceptibility. Conclusion: ZnT8 autoantibodies detection in ATD and/or CD patients is low, and routine ZnT8 screening is not justified. ZnT8 evaluation may be recommended in subjects with autoimmune diseases as a marker for predicting compromised insulin secretion.
© 2016 S. Karger AG, Basel
References
- Eisenbarth GS: Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986;314:1360-1368.
- Davidson HW, Wenzlau JM, O'Brien RM: Zinc transporter 8 (ZnT8) and β cell function. Trends Endocrinol Metab 2014;25:415-424.
- Kawasaki E: Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol 2014;23:99-105.
- Huang L: Zinc and its transporters, pancreatic β-cells, and insulin metabolism. Vitam Horm 2014;95:365-390.
- Wenzlau JM, Hutton JC: Novel diabetes autoantibodies and prediction of type 1 diabetes. Curr Diab Rep 2013;13:608-615.
- Kawasaki E: ZnT8 and type 1 diabetes. Endocr J 2012;59:531-537.
- Jaberi-Douraki M, Pietropaolo M, Khadra A: Predictive models of type 1 diabetes progression: understanding T-cell cycles and their implications on autoantibody release. PLoS One 2014;9:e93326.
- Jaberi-Douraki M, Liu SW, Pietropaolo M, Khadra A: Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of disease. Pediatr Diabetes 2014;15:162-174.
- Pietropaolo M, Towns R, Eisenbarth GS: Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med 2012;2.
- Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A: HLA-T1DM autoantibody frequency in celiac disease. Clinics (Sao Paulo) 2009;64:1195-1200.
- Moriguchi M, Noso S, Kawabata Y, Yamauchi T, Harada T, Komaki K, Babaya N, Hiromine Y, Ito H, Yamagata S, Murata K, Higashimoto T, Park C, Yamamoto A, Ohno Y, Ikegami H: Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity. Metabolism 2011;60:761-766.
- Marwaha RK, Garg MK, Tandon N, Kanwar R, Narang A, Sastry A, Saberwal A, Bhadra K: Glutamic acid decarboxylase (anti-GAD) and tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity. Indian J Med Res 2013;137:82-86.
- d'Annunzio G, Giannattasio A, Poggi E, Castellano E, Calvi A, Pistorio A, Barabino A, Lorini R: β-Cell autoimmunity in pediatric celiac disease: the case for routine screening? Diabetes Care 2009;32:254-256.
-
World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985 (Tech Reg Ser No 727).
- Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer JP, Sosenko JM, Skyler JS: Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care 2010;33:2508-2513.
- Lorini R, Vanelli M; Prediabetes Study Group of Italian Society for Pediatric Endocrinology and Diabetology (SIEDP): Normal values of first-phase insulin response to intravenous glucose in healthy Italian children and adolescents. Diabetologia 1996;39:370-371.
- Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279-1283.
- MacCuish AC, Irvine WJ, Barnes EW, Duncan LJP: Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 1974;2:1529-1531.
- Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151-156.
- Lan MS, Lu J, Goto Y, Notkins AL: Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994;13:505-514.
- Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104:17040-17045.
- Chimienti F, Devergnas S, Favier A, Seve M: Identification and cloning of a β-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 2004;53:2330-2337.
- Wijesekara N, Chimienti F, Wheeler MB: Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes Metab 2009;11(suppl 4):202-214.
- Hojsak I, Zevit N, Waisbourd-Zinman O, Rosenbach Y, Mozer-Glassberg Y, Shalitin S, Phillip M, Shamir R: Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease. J Pediatr Endocrinol Metab 2013;26:1099-1104.
- Andersen MK, Härkönen T, Forsblom C, Groop PH, Knip M, Tuomi T: Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes. Autoimmunity 2013;46:251-258.
- Trabucchi A, Faccinetti NI, Guerra LL, Puchulu FM, Frechtel GD, Poskus E, Valdez SN: Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 2012;45:137-142.
- Xu X, Gu Y, Bian L, Shi Y, Cai Y, Chen Y, Chen H, Qian L, Wu X, Xu K, Mallone R, Davidson HW, Yu L, She J, Zhang M, Yang T: Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes. Vaccine 2016;34:854-862.
- Florez JC, Hirschhorn J, Altshuler D: The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 2003;4:257-291.
- Zamani M, Pociot F, Spaepen M, Raeymaekers P, Nerup J, Cassiman JJ: Linkage and association of the HLA gene complex with IDDM in 81 Danish families: strong linkage between DR beta 1Lys71+ and IDDM. J Med Genet 1996;33:899-905.
- Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A: Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls. Eur J Immunogenet 1995;22:443-465.
- Park Y: Why is type 1 diabetes uncommon in Asia? Ann NY Acad Sci 2006;1079:31-40.
- Weintrob N, Sprecher E, Israel S, Pinhas-Hamiel O, Kwon OJ, Bloch K, Abramov N, Arbel A, Josefsberg Z, Brautbar C, Vardi P: Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel. Diabetes Care 2001;24:650-653.
- Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, Sipilä I, Akerblom HK, Ilonen J: HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003;62:162-169.
- Howson JM, Stevens H, Smyth DJ, Walker NM, Chandler KA, Bingley PJ, Todd JA: Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011;60:2635-2644.
- Salonen KM, Ryhänen S, Härkönen T, Ilonen J, Knip M; Finnish Pediatric Diabetes Register: Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Diabetes Metab Res Rev 2013;29:646-654.
- Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark Å, Pociot F; Danish Study Group of Childhood Diabetes: Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity 2011;44:107-114.
- Dang M, Rockell J, Wagner R, Wenzlau JM, Yu L, Hutton JC, Gottlieb PA, Davidson HW: Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8. J Immunol 2011;186:6056-6063.
Article / Publication Details
Received: May 03, 2016
Accepted: June 24, 2016
Published online: August 03, 2016
Issue release date: October 2016
Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 4
ISSN: 1663-2818 (Print)
eISSN: 1663-2826 (Online)
For additional information: https://www.karger.com/HRP
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission